Moreover, TF-targeted NIR-PIT demonstrated significant in vivo tumor control in murine xenograft models of pancreatic cancer and epithelioid cancer, as well as immunogenic cell death after treatment across multiple tumors. This evidence concerns the gene TF and pancreatic neoplasm.